Download PDF
Z Gastroenterol 2021; 59(04): 360-363
DOI: 10.1055/a-1375-1587
Kommentiertes Referat

Funktionelle Magen-Darm-Erkrankungen werden besser durch eine interdisziplinäre Behandlung als durch eine gastroenterologische Standardtherapie versorgt

Functional gastrointestinal disorders are treated more efficiently by a multidisciplinary approach than standard gastroenterological care
Thomas Frieling
1   Medizinische Klinik II, HELIOS Klinikum Krefeld, Krefeld, Deutschland
,
Joachim Labenz
2   Fachabteilung Innere Medizin, Diakonie Klinikum Jung-Stilling, Siegen, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Basnayake C, Kamm MA, Stanley A, Wilson-O’Brien A, Burrell K, Lees-Trinca I, Khera A, Kantidakis J, Wong O, Fox K, Talley NJ, Liew D, Salzberg MR, Thompson AJ. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol 2020, July 14, 2020, https://doi.org/10.1016/S2468-1253(20)30215-6.



Publication History

Article published online:
12 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Basnayake C, Kamm MA, Stanley A. et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol 2020; DOI: https://doi.org/10.1016/S2468-1253(20)30215-6.
    CrossrefPubMedGoogle Scholar
  • 2 Frieling T, Schemann M. Reizdarmsyndrom – Epidemiologie und Pathophysiologie. Der Gastroenterologe 2013; 8: 405-416
    CrossrefPubMedGoogle Scholar
  • 3 Schemann M. Reizdarm und Reizmagen – Pathophysiologie und Biomarker. Der Gastroenterologe 2017; 12: 114-129
    CrossrefPubMedGoogle Scholar
  • 4 Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016; 150: 1262-1279.e2
    CrossrefPubMedGoogle Scholar
  • 5 Sperber AD, Bangdiwala SI, Drossman DA. et al Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology 2020; ; published online April 12. DOI: https://doi.org/10.1053/j.gastro.2020.04.014.
    CrossrefPubMedGoogle Scholar
  • 6 Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987; 92: 1282-1284
    CrossrefPubMedGoogle Scholar
  • 7 Canavan C, West J, Card T. The economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40: 1023-1034
    CrossrefPubMedGoogle Scholar
  • 8 Layer P, Andresen V, Allescher H. et al Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie des Reizdarmsyndroms der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterologie 2021; (in Progress)
    PubMedGoogle Scholar
  • 9 Frieling T. Funktionsstörungen im Verdauungstrakt und funktionelle Magen-Darm-Erkrankungen. Arzneimitteltherapie 2017; 35: 308-317
    PubMedGoogle Scholar
  • 10 Frieling T. Irritable bowel syndrome-a misnomer?. Z Gastroenterol 2011; 49: 577-578 . doi: 10.1055/s-0031-1273323
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Enck P, Frieling T, Schemann M. Irritable bowel syndrom – disection of a disease. A 13-steps polemic. Z Gastroenterol 2017; 55: 679-684 . doi: 10.1055/s-0043-110574
    PubMedGoogle Scholar
  • 12 Basnayake C, Kamm MA, Salzberg M. et al. Outcome of hospital outpatient treatment of functional gastrointestinal disorders. Intern Med J 2019; 49: 225-231
    CrossrefPubMedGoogle Scholar
  • 13 Basnayake C, Kamm MA, Salzberg MR. et al. Delivery of care for functional gastrointestinal disorders: a systematic review. J Gastroenterol Hepatol 2020; 35: 204-210
    CrossrefPubMedGoogle Scholar
  • 14 Pinto-Sanchez MI, Ford AC, Avila CA. et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015; 110: 1038-1048
    CrossrefPubMedGoogle Scholar
  • 15 British Society of Gastroenterology. Care of patients with gastrointestinal disorders in the UK. A strategy for the future. Gut 2007; 56: 1-56
    PubMedGoogle Scholar
  • 16 Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med 2017; 376: 2566-2578
    CrossrefPubMedGoogle Scholar
  • 17 Halmos EP, Power VA, Shepherd SJ. et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75
    CrossrefPubMedGoogle Scholar
  • 18 Chiotakakou-Faliakou E, Kamm MA, Roy AJ. et al. Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut 1998; 42: 517-521
    CrossrefPubMedGoogle Scholar
  • 19 Drossman DA, Toner BB, Whitehead WE. et al. Cognitivebehavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19-31
    CrossrefPubMedGoogle Scholar
  • 20 Miller V, Carruthers HR, Morris J. et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 2015; 41: 844-855
    CrossrefPubMedGoogle Scholar
  • 21 Häuser W, Marshall U, Layer P. et al. Häufigkeit, Komorbiditäten, Versorgung und Kosten des Reizdarmsyndroms. Eine Beobachtungsstudie mit Routinedaten einer Krankenkasse. Dtsch Arztebl Int 2019; 116: 463-470
    PubMedGoogle Scholar
  • 22 https://www.barmer.de/presse/infothek/studien-und-reports/arztreporte/pm-arztreport-2019-192568
    PubMed
  • 23 Labenz J. Digitaler Wandel des Krankheitsmanagements am Beispiel der GERD. Die ALGK informiert. Z Gastroenterol 2020; 58: 1021-1024
    Article in Thieme ConnectPubMedGoogle Scholar